"10.1371_journal.pone.0102897","plos one","2014-07-18T00:00:00Z","Vanessa C Delisle; Linda Kwakkenbos; Marie Hudson; Murray Baron; Brett D Thombs; the Canadian Scleroderma Research Group","Department of Educational and Counselling Psychology, McGill University, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Department of Psychology, McGill University, Montreal, Quebec, Canada; School of Nursing, McGill University, Montreal, Quebec, Canada; The Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada","Conceived and designed the experiments: VD LK MH MB BT. Performed the experiments: VD LK BT. Analyzed the data: VD LK BT. Contributed reagents/materials/analysis tools: MH MB. Contributed to the writing of the manuscript: VD LK MH MB BT.","The authors have the following interests: INOVA Diagnostics Inc. (San Diego, CA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), Pfizer, and Actelion pharmaceuticals have provided unrestricted educational and research funds to the Canadian Scleroderma Research Group. There are no patents, products in development or marketed products to declare. The authors confirm that co-author Dr. Brett D. Thombs is a PLOS ONE Editorial Board Member. This does not alter the authors adherence to PLOS ONE Editorial policies and criteria.","2014","07","Vanessa C Delisle","VCD",6,TRUE,5,3,3,NA,TRUE,TRUE,TRUE,1,"6",TRUE
